Seyltx logo

Seyltx jobs and careers

About Seyltx

Seyltx is a late clinical-stage pharmaceutical company leveraging new insights into how the brain functions to selectively target the "master switch" of the cough reflex to address refractory chronic cough - a condition that 4-5 million people in the US alone suffers from.

Employees
1 to 10

Leadership

The top of Seyltx's org chart, with how many people report into each leader.

MBPhoto of Michael Bassoff

Michael Bassoff

Co-Founder